Each filer's latest filing for 00973N102 since 12/18/2024, largest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
MPM Bioventures 2018, L.P.
13D
|
19.3% |
1/20/2026
Event 1/12/2026
|
|
| MPM Bioventures 2018, L.P. | 7.4% | ||
| MPM Bioventures 2018 (B), L.P. | 0.4% | ||
| MPM BioVentures 2018 GP LLC | 7.8% | ||
| MPM Asset Management Investors BV2018 LLC | 0.1% | ||
| MPM BioVentures 2018 LLC | 7.9% | ||
| MPM Oncology Innovations Fund LP | 1.6% | ||
| MPM Oncology Innovations Fund GP LLC | 1.6% | ||
| Oncology Impact Private Investment Fund 2, L.P. | 9.1% | ||
| MPM Oncology Investments 2 LLC | 9.1% | ||
| MPM Asset Management LLC | 0.6% | ||
| Ansbert Gadicke | 19.3% | ||
| Luke Evnin | 9.5% | ||
| Todd Foley | 8.0% | ||
| ELI LILLY & Co 13D | 11.9% |
1/15/2026
Event 1/12/2026
|
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 1 | 2.00 k | $0 |
| 2026 Q2 | 1 | 2.00 k | $0 |
| 2025 Q4 | 2 | 27.8 k | $0 |
| 2025 Q1 | 2 | 28.8 k | $186 |
| 2024 Q4 | 9 | 528 k | $2.33k |
| 2024 Q3 | 79 | 21.3 M | $1.91M |
| 2024 Q2 | 92 | 23.3 M | $3.07M |
| 2024 Q1 | 118 | 41.2 M | $24.4M |
| 2023 Q4 | 112 | 29.0 M | $38.4M |
| 2023 Q3 | 122 | 33.0 M | $25.6M |
| 2023 Q2 | 133 | 37.4 M | $119M |
| 2023 Q1 | 139 | 35.9 M | $120M |
| 2022 Q4 | 122 | 26.8 M | $75.6M |
| 2022 Q3 | 127 | 28.1 M | $84.0M |
| 2022 Q2 | 137 | 29.1 M | $106M |
| 2022 Q1 | 134 | 28.8 M | $187M |
| 2021 Q4 | 152 | 27.8 M | $184M |
| 2021 Q3 | 144 | 26.2 M | $251M |
| 2021 Q2 | 142 | 24.7 M | $265M |
| 2021 Q1 | 150 | 22.6 M | $295M |
| 2020 Q4 | 130 | 17.9 M | $219M |
| 2020 Q3 | 112 | 15.4 M | $126M |
| 2020 Q2 | 113 | 16.0 M | $132M |
| 2020 Q1 | 96 | 14.8 M | $79.6M |
| 2019 Q4 | 103 | 15.2 M | $122M |
| 2019 Q3 | 87 | 9.60 M | $74.4M |
| 2019 Q2 | 77 | 11.3 M | $72.0M |
| 2019 Q1 | 65 | 6.79 M | $39.8M |
| 2018 Q4 | 55 | 6.37 M | $31.6M |
| 2018 Q3 | 40 | 3.36 M | $26.4M |
| 2018 Q2 | 37 | 3.26 M | $23.7M |
| 2018 Q1 | 42 | 3.20 M | $18.6M |
| 2017 Q4 | 43 | 2.76 M | $17.2M |
| 2017 Q3 | 34 | 2.10 M | $13.7M |
| 2017 Q2 | 32 | 1.39 M | $12.1M |
| 2017 Q1 | 13 | 749 k | $9.49M |